miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
Rosanna Sestito(Istituti di Ricovero e Cura a Carattere Scientifico), Anna Bagnato(National Cancer Institute)
Cited by 51
Related Papers
Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer
|Communications Biology|2020|28
The endothelin-1-driven tumor-stroma feed-forward loops in high-grade serous ovarian cancer
|Clinical Science|2024|5
YAP signaling orchestrates the endothelin-1-guided invadopodia formation in high-grade serous ovarian cancer
|Bioscience Reports|2024|1
Nuclear gasdermin E drives endothelin-1-induced metastatic progression independently of the pyroptosis
|Cell Death and Disease|2026|0